We studied reactivity of cytokeratins (CK) 7, 17, and 20 Pancreaticobiliary adenocarcinomas can be difficult to diagnose because the primary tumor can be occult, its signs and symptoms can mimic those produced by other adenocarcinomas, and they share morphologic features with other adenocarcinomas, especially those in the stomach. The cytokeratin (CK) immunophenotype of an adenocarcinoma can assist in the identification of its primary site; CK7 and CK20 are two of the most extensively studied. Wang et al 1 were the first to use CK7 and CK20 in tandem, producing 4 CK7 and CK20 coordinate staining patterns based on positive and negative reactivity. The number of pancreaticobiliary adenocarcinomas studied in this manner is small, and the reported distribution of CK7 and CK20 coordinate staining varies to such a degree that no consistent staining pattern can be elicited. [1] [2] [3] [4] One reason for the spectrum of reported staining patterns may be methodologic. Differences in the percentage of reactive cells necessary for a positive result could substantially alter the distribution of CK7 and CK20 results.
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Another factor that has contributed to inconsistent CK staining results may be inclusion of ampulla of Vater adenocarcinomas with pancreatic duct and common bile duct adenocarcinomas. One group of authors reported ampullary adenocarcinomas had a CK immunophenotype similar to bowel adenocarcinomas that was distinct from pancreaticobiliary adenocarcinomas. 3 Last, a preliminary study of 17 formalin-fixed paraffin embedded, pancreatic adenocarcinomas reported that CK17 was potentially useful for identifying pancreatic adenocarcinomas. 5 Confirmation of these results and additional experience with CK17 reactivity is needed before it can be integrated into an antibody panel.
We studied the CK immunophenotype of 64 adenocarcinomas derived from pancreaticoduodenal resection specimens to clarify their CK7-CK20 coordinate reactivity and to provide additional experience with CK17 staining of pancreatic and ampulla of Vater adenocarcinomas. We also explored whether there were differences in the CK expression between ampulla of Vater and pancreatic duct adenocarcinomas.
Materials and Methods
From the files of William Beaumont Hospital Surgical Pathology Department (Royal Oak, MI), we identified 93 consecutive cases of carcinoma treated by pancreaticoduodenal resection from January 1995 through December 2000. Slides were reviewed from each case, and cases were excluded if they were not primary ampullary invasive adenocarcinoma or pancreaticobiliary invasive adenocarcinoma. Undifferentiated, giant cell, acinic, and neuroendocrine carcinomas were excluded. No distinction between pancreatic duct and intrapancreatic common bile duct was made. In situ carcinoma components, either intraductal within the pancreas or ampulla of Vater adenoma, were excluded from evaluation.
The 64 remaining specimens constituted the study group. Each adenocarcinoma was classified into 1 of 3 groups based on the tissue(s) infiltrated by the adenocarcinoma to determine whether there were staining differences between ampullary and pancreatic adenocarcinomas. The 3 tumor groups were:
1. Ampulla only, defined as invasive adenocarcinoma involving the ampulla and periampullary duodenum, with maximal extension no farther than the outer layer of the duodenal muscularis propria. One block of invasive ampullary adenocarcinoma was chosen for immunohistochemical staining from each case.
2. Pancreas only, defined as invasive adenocarcinoma confined to the pancreas and peripancreatic soft tissues without involvement of the duodenal muscularis propria or ampulla of Vater. One block of invasive pancreatic adenocarcinoma was chosen for immunohistochemical staining from each case.
3. Ampulla and pancreas, defined as invasive adenocarcinoma involving the ampulla, duodenum, and pancreatic parenchyma. Two blocks were chosen for immunohistochemical staining from each case. One block contained only invasive adenocarcinoma from the ampulla, and the second block contained only invasive adenocarcinoma from the pancreas parenchyma.
Immunohistochemical Staining
We cut 3-µm-thick consecutive sections from each block, and each section was placed on a charged slide. Sections were deparaffinized using sequential immersions into 2 xylene baths, 3 baths of decreasing alcohol concentrations, and 2 water baths, followed by a 1-minute wash in water.
Slides were immersed in EDTA buffer (pH 7.0) and put into a commercial vegetable steamer at 95°C for 30 minutes. The slides were allowed to cool on the countertop, remaining immersed in the heated EDTA buffer-filled containers for 5 minutes, followed by a 2-minute rinse with water while remaining in the containers. The slides were transferred into tris(hydroxymethyl)aminomethane-filled containers (pH 7.0) and allowed to cool for an additional 10 minutes on the countertop. They then were transferred to a commercial immunohistochemistry autostainer (DAKO, Carpinteria, CA) and were first washed with buffer, followed by a hydrogen peroxide incubation. The latter was rinsed off, and the primary antibody was applied. The primary antibody was incubated over the sections for 20 minutes at room temperature. After the primary antibody was washed off, the components of the Envision-plus (DAKO) detection system were applied, including an antimouse polymer, 2 distilled-water washes, and a final diaminobenzidine incubation for 4 minutes. Sections were counterstained with hematoxylin and coverslipped. A positive control slide, containing known CK-reactive tissues was stained with each batch of simultaneously stained slides.
A slide from each study block was stained with CK 19 as a positive control of adenocarcinoma cell integrity. Cytokeratin 19 strongly and diffusely stains pancreaticobiliary and ampulla of Vater adenocarcinomas. [6] [7] [8] All of the adenocarcinomas in the study had strong and diffuse cytoplasmic CK19 reactivity.
All of the primary antibodies were obtained from DAKO. The following antibody clones and dilutions were used: CK7 (clone OV-TL-12/30, 1:800 dilution), CK17 (clone E3, 1:200 dilution), CK19 (clone RCK108, 1:50 dilution), and CK20 (clone K S 20.8, 1:500 dilution).
The percentage of reactive invasive adenocarcinoma cells was quantified as 0%, less than 5%, 5% to 25%, 26% to 50%, 51% to 75%, or more than 75%. Intensity of stained cells was quantified into 1 of 3 categories: (1) weak reactivity: required high magnification to detect; (2) moderate reactivity: could be seen easily at medium magnification and after careful examination at low magnification; (3) strong reactivity: staining could be seen easily at low magnification.
Results

Cytokeratins 7 and 20
Ampulla-Only Adenocarcinomas
Cytokeratin 7 was strongly reactive in all 7 adenocarcinomas (100%) ❚Table 1❚, ❚Image 1❚. CK20 reactivity was heterogeneous. All of the neoplastic cells were strongly CK20 reactive in 3 adenocarcinomas (43%), but 4 adenocarcinomas (57%) were nonreactive. The CK20-reactive and nonreactive adenocarcinomas were morphologically similar.
Pancreas-Only Adenocarcinomas
CK7 was strongly reactive in more than 50% of the adenocarcinoma cells in all 35 neoplasms (100%). CK20 was nonreactive or showed rare individual cell (<5%) staining in 24 (69%) of 35 adenocarcinomas. Four (11%) adenocarcinomas had CK20 reactivity in less than one half of their cells, and 6 (17%) neoplasms had reactivity in more than one half of their cells ❚Image 2❚. The intensity of CK20 was proportional to the number of reactive cells: weak in the 4 adenocarcinomas with rare individual cell (<5%) reactivity, moderate in the 1 case with 5% to 25% reactive cells, and strong in the 9 cases with reactivity in more than 25% of the neoplastic cells.
Ampulla and Pancreas
Strong CK7 reactivity was present in greater than 75% of the adenocarcinoma cells in 20 (91%) of 22 adenocarcinomas. ❚Image 1❚ Diffuse cytokeratin 7 reactivity in an ampulla-only adenocarcinoma (hematoxylin, ×6.25).
❚Image 2❚ Cytokeratin 20 expression in a pancreas-only adenocarcinoma. More than 75% of the cells are reactive (hematoxylin, ×112).
Fifteen (68%) of the adenocarcinomas had no or rare (<5%) CK20-reactive cells (these were of weak intensity). Five adenocarcinomas (23%) had strong CK20 reactivity in more than 50% of their cells.
Cytokeratin 17
Ampulla-Only Adenocarcinomas All neoplastic cells were strongly CK17 reactive in 1 (14%) of 7 adenocarcinomas (Table 1) . This neoplasm was composed of small and medium-sized glands that were lined by cuboidal and columnar mucinous cells. Cytokeratin 17 stained less than 5% (rare cells) of the tumor cells in 2 cases (29%), 1 each with weak and moderate intensity.
Pancreas-Only Adenocarcinomas
Of the 35 pancreas-only adenocarcinomas, 12 (34%) had no CK17 reactivity, 8 (23%) had reactivity in 5% to 50% of neoplastic cells, and 15 (43%) had reactivity in more than half of their cells ❚Image 3❚ and ❚Image 4❚. The staining intensity was predominantly moderate. Occasional clusters or individual cells had strong CK17 reactivity. CK17-reactive cells were most often arranged as single cells or in small groups. Adenocarcinoma cells that comprised abortive glands were less often CK17 reactive, but occasional glands that were lined by cuboidal and columnar mucous cells had strong reactivity. Cells comprising well-formed neoplastic glands also expressed CK17, but in a more patchy distribution. CK17 also was present in small to medium-sized nests of neoplastic cells with clear or abundant eosinophilic, squamous-like cytoplasm. Most of the adenocarcinomas that were CK17 reactive were typical adenocarcinomas.
Ampulla and Pancreas
Of the 22 adenocarcinomas, 9 (41%) had no CK17 reactivity, 2 (9%) had weak reactivity in rare (<5%) cells, and 8 (36%) had moderate or strong reactivity in 5% to 50% of the neoplastic cells ❚Image 5❚. More than half of the adenocarcinoma cells were CK17 reactive in 3 (14%) adenocarcinomas, all of which were of moderate to strong intensity. The cytologic features of CK17-reactive cells were identical to those of pancreas-only adenocarcinomas. adenocarcinomas (any location) increased from 35 (55%) to 45 (70%), the number of CK7+/CK20+ adenocarcinomas decreased from 29 (45%) to 18 (28%), and 1 adenocarcinoma (2%) became CK7-/CK20+ when the positive cutpoint increased from any (>0%) reactivity to more than 25%.
Positive Cases and Cut-Point Thresholds
Ampullary vs Pancreatic Adenocarcinomas
CK7 and CK20 reactivity in ampulla of Vater and pancreas adenocarcinomas was compared in 2 ways. The first examined the immunoreactivity of adenocarcinomas that were limited to the ampulla or pancreas. The second compared the immunoreactivity of adenocarcinoma involving the ampullary and pancreas regions in adenocarcinomas that involved both sites.
Ampulla-Only vs Pancreas-Only Adenocarcinomas
The distribution of CK7 and CK20 reactivity was similar in ampulla-only and pancreas-only adenocarcinomas (Table 1) . Almost all adenocarcinomas from both sites were diffusely CK7 reactive. Three (43%) of 7 and 14 (40%) of 35 ampulla of Vater and pancreas adenocarcinoma, respectively, were CK20 reactive. Pancreas-only adenocarcinomas had a broader spectrum of percentages of CK20-reactive cells compared with ampullary-only adenocarcinomas, but this may have been a reflection of the small number (7) of ampulla-only adenocarcinomas included in the study.
Tumors Involving Both Sites
CK7 and CK20 reactivity in the ampullary and pancreas regions of adenocarcinomas that involved both sites is given in ❚Table 4❚. The values in these tables differ from those in Table 1 because the percentage of reactive cells in Table 1 was from the assessment of adenocarcinomas in both the pancreas and ampulla regions, whereas Table 4 individually lists the reactivity of adenocarcinomas in each region.
The percentages of CK7 and CK20 reactivity of adenocarcinoma cells in the two regions were identical or within a quartile of each other in 20 (91%) of 22 adenocarcinomas. The 2 adenocarcinomas with disparate CK7 reactivity were not the same as the 2 adenocarcinomas with disparate CK20 reactivity.
Discussion
In this study of 64 pancreaticobiliary adenocarcinomas, CK7 strongly stained almost all pancreaticobiliary adenocarcinoma cells. Approximately 50% of pancreaticobiliary adenocarcinomas were CK20 nonreactive. Only 22% had CK20 reactivity in more than one-half of their neoplastic cells. In tandem, the CK7+/CK20-pattern was most common, comprising 55% to 75% of the neoplasms, depending on the percentage of reactive cells used as the cutpoint threshold for a positive result.
In general, the staining results of CK7 reactivity in the present study were similar to those reported by others, which ranged from 69% to 100%. 3, [8] [9] [10] [11] [12] [13] [14] [15] Most authors who used formalin-fixed paraffin-embedded tissue sections reported a lower percentage of CK7-reactive adenocarcinomas, 3, 12 compared with those who used frozen tissue blocks and postfixed acetone or alcohol-fixed sections. [8] [9] [10] [11] 14, 15 The results for CK20 in the present study also are similar to those reported by others, with reactivity in more than half of tumor cells occurring in 30% to 50% of pancreaticobiliary adenocarcinomas. 1, 3, 12, 16, 17 The CK7+/CK20-pattern was the predominant type of coordinate reactivity. This is identical to the results of 2 of the 3 studies reported in the literature 1,3,12 ❚Table 5❚. Aside from this finding, the overall distribution of CK7/CK20 reactivity reported for the 3 studies differs to such a degree that no other conclusions can be drawn. Several factors probably contribute to these disparate results. Technical differences between these studies include the method of antigen retrieval, staining protocols, and clones and dilutions of primary antibodies. A small number of studied cases is the second contributing factor. The 3 other studies together reported 69 pancreaticobiliary adenocarcinomas. Last, and probably most important, all 3 studies used a different cutpoint of antibody reactivity necessary for a positive result, ranging from any (>0%) to 25% of cells. As the present study demonstrated, varying the cut-point of reactive cells can alter the percentage of single antibody-positive cases and shift the distribution of reactivity when CK7 and CK20 are used in tandem.
There is no standardized or universal cut-point for immunoreactivity. The percentage of reactive cells necessary for a positive result seems to reflect the viewpoints and opinions of authors. We emphasize these points so that readers and students of immunohistochemistry are aware that there Pancreas region
can be significant methodologic differences between studies and aware of the potential effect of these differences on a study's results. For the same reasons, we caution against overreliance on immunohistochemical meta-analysis lists, such as can be found on some immunohistochemistry-related Internet Web sites (http://www.immunoquery.com). Ampulla of Vater and pancreas adenocarcinomas had similar distributions of individual antibody and of CK7 and CK20 coordinate reactivity in the present study. We do not find these results surprising, given the morphologic similarity, the continuity of ductal structures connecting the 2 regions, and the proximity of the neoplasms. Ampulla of Vater adenocarcinomas have been found to arise primarily within the common bile duct channel, the orifice of the papilla, or the pancreatic duct. 18 The pattern of CK7 and CK20 coordinate staining cannot be used to classify whether an endoscopically procured adenocarcinoma originates in the pancreas or ampulla of Vater. Our results on this question differ from one study that found ampulla of Vater adenocarcinoma had a CK7 and CK20 immunophenotype that was similar to bowel adenocarcinomas and distinct from pancreaticobiliary adenocarcinomas. 3 The authors of this study used a 25% reactivity cut-point for a positive reaction. They found that 4 (80%) of 5 ampulla of Vater adenocarcinomas had a CK7+ or CK7-/CK20+ coordinate staining reaction compared with 0 of 17 pancreaticobiliary adenocarcinomas. Three of the 4 CK20+ ampulla of Vater adenocarcinomas were CK7-, and 1 was CK7+. The fifth ampullary adenocarcinoma had a CK7-/CK20-reaction pattern. By using the identical cut-point for a positive staining reaction, all 7 of the ampulla of Vater invasive adenocarcinomas in the present study were CK7+, 4 were CK20-, and 3 were CK20+. However, the number of pure ampulla of Vater neoplasms in the present study was small because of our restrictive definition (ampulla of Vater-centered adenocarcinomas did not extend beyond the outer layer of the duodenal muscularis propria). We also addressed the question of whether ampulla of Vater or pancreaticobiliary duct adenocarcinoma cells can alter their CK immunophenotype in response to the tissue milieu that surrounds them. Such an immunophenotypic transformation could help to explain the differences in CK7 and CK20 coordinate reactivity between the 2 studies. We found no evidence of such a process; adenocarcinomas involving the pancreas and ampulla of Vater regions were almost always similar.
There are 2 possible explanations for the differences in CK7-CK20 coordinate staining patterns in this and the aforementioned study. 3 First, the rules used to define and separate ampulla of Vater from pancreatic adenocarcinomas are probably different. We applied the restrictive criteria mentioned to ensure that all adenocarcinomas in that group arose from within the ampulla of Vater complex. The criteria are not mentioned in the text of the other study except for the comment that 5 ampulla of Vater tumors had been previously diagnosed as such. Second, we evaluated the staining reaction only in invasive adenocarcinoma cells and ignored reactivity in adenomatous or adenocarcinoma in situ cells. Although one would think the authors of the other study also limited their evaluation to invasive adenocarcinoma cells, the 3 photographs in their Figure 1 of "moderately differentiated ampullary adenocarcinoma" are adenocarcinoma in situ that has a sharp transition with normal bile duct epithelium.
CK17 is strongly expressed in benign stratified epithelium and has been classified by Moll 7, 19 and Moll et al 20 along with CK5 and CK14 as a stratified epithelial CK. To our knowledge, only 1 group of authors has studied CK17 reactivity in formalin-fixed paraffin-embedded pancreaticobiliary adenocarcinomas. 5 These authors concluded, after examining CK17 reactivity in a large number of carcinomas from different locations throughout the body, that this antibody may be useful for assisting in the identification of pancreaticobiliary adenocarcinomas. The CK17 reactivity of our 64 neoplasms is similar but does not exactly replicate that of the other study. Five (29%) of 17 pancreaticobiliary adenocarcinomas in the other study had no reactivity or stained rare, single neoplastic cells compared with 45% of the adenocarcinomas in our study. In the other study, 29% of the adenocarcinomas had reactivity in 10% to 50% of the neoplastic cells, compared with 25% of the adenocarcinomas in our study. Last, 12% of the adenocarcinomas in the other study had staining in more than 50% of the neoplastic cells, compared with 30% of the adenocarcinomas in our study. These authors also noted that CK17 reactivity was prominent in areas of adenosquamous differentiation, but many tumors without squamous differentiation had substantial reactivity. One possible reason for these minor staining distribution differences is the number of cases in each study, 17 in the other study, compared with 64 in ours. Other authors, using frozen tissue, postfixed in acetone, report greater reactivity. 21 Our results support those reported by other authors, that CK17 can be a useful antibody (when positive) for the identification of pancreaticobiliary adenocarcinomas. 5 It is our experience that CK17 is useful for distinguishing pancreaticobiliary and gastric adenocarcinomas. These two neoplasms share morphologic features and have close anatomic proximity. They also have identical CK7 and CK20 reaction patterns. Goldstein et al 22 recently studied the CK immunophenotype of 46 gastric signet and glandular adenocarcinomas, none of which were CK17 reactive. Therefore, CK17 reactivity supports a pancreaticobiliary-primary adenocarcinoma. 5, 22 Primary pancreatic and ampulla of Vater adenocarcinomas have similar CK7 and CK20 immunophenotypes. CK7 and CK20 coordinate staining should not be used to identify whether adenocarcinoma in endoscopically procured biopsy specimens originates in the pancreas or ampulla of Vater. Single antibody staining results, especially CK7 and CK20 coordinate reactivity, are influenced by the reactivity cut-point chosen by the authors. Pathologists should be aware of these factors when interpreting the immunohistochemistry literature. Cytokeratin 17 is reactive in a minority of pancreaticobiliary adenocarcinomas but seems to be useful for helping to distinguish pancreaticobiliary and gastric adenocarcinomas.
